Evaluation of the Nurse-Led Symptom Management Program for Patients With Gynecologic Cancer Undergoing Chemotherapy

BACKGROUND Patients with cancer experience symptoms concurrently. Nurses need to make multisymptom management and educate patients about self-management strategies. OBJECTIVE The aim of this study was to evaluate the effect of a nurse-led symptom management program (NL-SMP), developed based on the Symptom Management Model, quality of life (QoL), and symptom severity of women with gynecological cancer undergoing chemotherapy. METHODS This randomized controlled study sample consisted of 41 women receiving chemotherapy at an outpatient clinic in Istanbul, Turkey, between November 2018 and December 2019. European Organisation for Research and Treatment of Cancer Quality-of-Life Scale, Edmonton Symptom Assessment Scale, and Modified Brief Sexual Symptom Checklist-Women were used to collect data. Women were randomly assigned to 2 groups: intervention (n = 21) and control (n = 20). The intervention group attended the NL-SMP in addition to usual care. Data were collected at the first (time 1), third (time 2), and last chemotherapy cycle (time 3). Repeated measures analysis of variance, Cochran-Q, and t tests were used to analyze the data. RESULTS In the intervention group, the QoL was significantly higher; symptom severity was lower than that of the control group at time 2 and time 3. At time 3, more women in the control group reported at least 1 sexual difficulty and were not satisfied with their sexual function, whereas there was no change for women in the intervention group. CONCLUSION The NL-SMP, which consisted of systematic symptom assessment, prioritization of symptoms, providing symptom, and patient-specific education, decreased deterioration in the QoL and symptom severity of women. IMPLICATIONS FOR PRACTICE Conducting multisymptom assessments, prioritizing symptoms, providing symptom- and patient-specific education, and supporting symptom self-management throughout treatment can lead to effective symptom management.

[1]  A. Ross-White,et al.  The needs of gynecological cancer survivors at the end of primary treatment: A scoping review and proposed model to guide clinical discussions. , 2021, Patient education and counseling.

[2]  A. Marshall,et al.  Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment , 2021, Oncology and Therapy.

[3]  J. Levine,et al.  Stability of Symptom Clusters in Patients With Gynecologic Cancer Receiving Chemotherapy , 2021, Cancer nursing.

[4]  S. Peters,et al.  Pilot Testing of a Nurse-Led Basic Symptom Self-management Support for Patients Receiving First-Line Systemic Outpatient Anticancer Treatment , 2021, Cancer nursing.

[5]  J. Lowe,et al.  Factors of sexual quality of life in gynaecological cancers: a systematic literature review , 2021, Archives of Gynecology and Obstetrics.

[6]  M. D. dos Santos,et al.  Experience of Sexuality in Women with Gynecological Cancer: Meta-Synthesis of Qualitative Studies , 2021, Cancer investigation.

[7]  A. McCarthy,et al.  Symptom clusters experienced by breast cancer patients at various treatment stages: A systematic review , 2021, Cancer medicine.

[8]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[9]  G. Ranieri,et al.  Peripheral Neuropathy under Oncologic Therapies: A Literature Review on Pathogenetic Mechanisms , 2021, International journal of molecular sciences.

[10]  F. Homaei Shandiz,et al.  Spousal sexual life issues after gynecological cancer: a qualitative study , 2021, Supportive Care in Cancer.

[11]  Dalex Pernelle,et al.  Sexual, psychological, interpersonal well-being and (unmet) supportive care needs of couples after a gynecological cancer treatment , 2021, European Journal of Gynaecological Oncology.

[12]  N. Uysal,et al.  Evaluation of Sexual Life in Patients with Gynecologic Cancer Undergoing Radiotherapy , 2020, Sexuality and Disability.

[13]  K. Kwekkeboom,et al.  Guideline-Recommended Symptom Management Strategies That Cross Over Two or More Cancer Symptoms. , 2020, Oncology nursing forum.

[14]  H. Gage,et al.  Holistic needs assessment and care plans for women with gynaecological cancer: do they improve cancer-specific health-related quality of life? A randomised controlled trial using mixed methods , 2017, BMJ Supportive & Palliative Care.

[15]  P. Young,et al.  Adjusting to sex and intimacy: Gynecological cancer survivors share about their partner relationships , 2020, Journal of women & aging.

[16]  L. Brotto,et al.  Sexual Function, Quality of Life, and Experiences of Women with Ovarian Cancer: A Mixed-Methods Study , 2019, Sexual medicine.

[17]  A. McCarthy,et al.  The Effect of Nonpharmacological Interventions on Managing Symptom Clusters Among Cancer Patients , 2019, Cancer nursing.

[18]  L. Uhlmann,et al.  The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial , 2019, Cancer medicine.

[19]  P. Cohen,et al.  Screening for sexual health concerns in survivors of gynecological cancer , 2019, Supportive Care in Cancer.

[20]  R. J. T. Sekse,et al.  Lived experiences and quality of life after gynaecological cancer—An integrative review , 2019, Journal of clinical nursing.

[21]  P. Fayers,et al.  General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States. , 2019, European journal of cancer.

[22]  Carenx W. Y. Leung,et al.  A Nurse-Led Care Program for Breast Cancer Patients in a Chemotherapy Day Center: A Randomized Controlled Trial , 2017, Cancer nursing.

[23]  R. Vogel,et al.  Sexual quality of life after the treatment of gynecologic cancer: what women want , 2019, Supportive Care in Cancer.

[24]  C. Amidei,et al.  Symptom-based interventions to promote quality survivorship. , 2018, Neuro-oncology.

[25]  P. Beale,et al.  Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  K. Mooney,et al.  SymptomCare@Home: Developing an Integrated Symptom Monitoring and Management System for Outpatients Receiving Chemotherapy , 2017, Computers, informatics, nursing : CIN.

[27]  H. Mayer,et al.  Effectiveness, structure, and content of nurse counseling in gynecologic oncology: a systematic review , 2017, BMC Nursing.

[28]  E. Bruera,et al.  The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments. , 2017, Journal of pain and symptom management.

[29]  Shu-Fen Wu,et al.  The Exploration of Health-Related Quality of Life , 2017, Clinical nursing research.

[30]  R. M. Bakker,et al.  A nurse-led sexual rehabilitation intervention after radiotherapy for gynecological cancer , 2016, Supportive Care in Cancer.

[31]  W. Zhuang,et al.  Symptom Clusters in Ovarian Cancer Patients With Chemotherapy After Surgery: A Longitudinal Survey , 2016, Cancer nursing.

[32]  L. Derogatis,et al.  Recommendations for the clinical evaluation of men and women with sexual dysfunction. , 2010, The journal of sexual medicine.

[33]  A. Bottomley,et al.  Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients. , 2007, European journal of cancer care.

[34]  A. Karadakovan,et al.  Validity and Reliability of the Edmonton Symptom Assessment Scale in Turkish Cancer Patients , 2008 .

[35]  J. Higginson,et al.  International Agency for Research on Cancer. , 1968, WHO chronicle.